GGrantIndex
← Leaderboards

Kenneth W Gross

Roswell Park Cancer Institute Corp

$7,053,357
Attributed
$9,072,054
Total exposure
7
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $830.9K · FY200618
$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18

Funding mix

By agency

NIH$9,072,054 · 7

By mechanism

R01$6,921,074 · 2
R21$1,191,171 · 3
R24$533,425 · 1
P30$426,384 · 1

Top collaborators

Most similar at Roswell Park Cancer Institute Corp

Same institution · by research overlap

Others in their field

Top investigators on “Renin

Research focus

ReninGeneticGenesCellsCell LinePhenotypeExhibitsReporterKidney CellStagingTransgenic OrganismsLaboratoriesKidneyTumorRegulationTranscription FactorBaseMemberAnimal ModelBlood VesselsSourceMouse ModelPathway InteractionsHypertension

Grant awards (31)

Juxta-glomerular cells serve as glomerular epithelial cell progenitors in glomeru$531,914
R01 · FY2018 · DK
Juxta-glomerular cells serve as glomerular epithelial cell progenitors in glomeru$539,066
R01 · FY2017 · DK
Juxta-glomerular cells serve as glomerular epithelial cell progenitors in glomeru$546,042
R01 · FY2016 · DK
Juxta-glomerular cells serve as glomerular epithelial cell progenitors in glomeru$552,845
R01 · FY2015 · DK
Juxta-glomerular cells serve as glomerular epithelial cell progenitors in glomeru$577,974
R01 · FY2014 · DK
Epi)Genomic drivers of primary and metastatic pancreatic islet cell carcinoma$170,128
R21 · FY2014 · CA · contact PI
Epi)Genomic drivers of primary and metastatic pancreatic islet cell carcinoma$29,610
R21 · FY2014 · CA · contact PI
Epi)Genomic drivers of primary and metastatic pancreatic islet cell carcinoma$213,747
R21 · FY2013 · CA · contact PI
A novel murine model for metastatic islet cell pancreas cancer$188,490
R21 · FY2013 · CA · contact PI
Epi)Genomic drivers of primary and metastatic pancreatic islet cell carcinoma$20,255
R21 · FY2013 · CA · contact PI
Kidney Progenitor Cells in Disease$533,425
R24 · FY2012 · DK
A novel murine model for metastatic islet cell pancreas cancer$219,599
R21 · FY2012 · CA · contact PI
Gene Targeting & Transgenics$77,904
P30 · FY2012 · CA · contact PI
Gene Targeting & Transgenics$84,178
P30 · FY2011 · CA · contact PI
Renin-expressing Cell Lines for Hypertension Research$464,126
R01 · FY2010 · HL · contact PI
Gene Targeting & Transgenics$91,990
P30 · FY2010 · CA · contact PI
Renin-expressing Cell Lines for Hypertension Research$459,808
R01 · FY2009 · HL · contact PI
Gene Targeting & Transgenics$88,344
P30 · FY2009 · CA · contact PI
Renin-expressing Cell Lines for Hypertension Research$446,221
R01 · FY2008 · HL · contact PI
Gene Targeting & Transgenics$31,038
P30 · FY2008 · CA · contact PI
Renin-expressing Cell Lines for Hypertension Research$432,964
R01 · FY2007 · HL · contact PI
Evaluation of Pericyte Molecular Markers in Clear Cell Kidney Cancer$182,523
R21 · FY2007 · CA · contact PI
CORE--GENE TARGETING AND TRANSGENICS$52,930
P30 · FY2007 · CA · contact PI
Renin-expressing Cell Lines for Hypertension Research$454,905
R01 · FY2006 · HL · contact PI
Evaluation of Pericyte Molecular Markers in Clear Cell Kidney Cancer$166,819
R21 · FY2006 · CA · contact PI
RENIN-EXPRESSING CELL LINES FOR HYPERTENSION RESEARCH$397,971
R01 · FY2004 · HL
RENIN-EXPRESSING CELL LINES FOR HYPERTENSION RESEARCH$392,933
R01 · FY2003 · HL
RENIN-EXPRESSING CELL LINES FOR HYPERTENSION RESEARCH$388,042
R01 · FY2002 · HL
RENIN-EXPRESSING CELL LINES FOR HYPERTENSION RESEARCH$75,000
R01 · FY2002 · HL
RENIN-EXPRESSING CELL LINES FOR HYPERTENSION RESEARCH$383,294
R01 · FY2001 · HL
RENIN EXPRESSING CELL LINES FOR HYPERTENSION RESEARCH$277,969
R01 · FY2000 · HL